Results 61 to 70 of about 350,478 (232)

Continued control of pneumococcal disease in the UK - the impact of vaccination

open access: yes, 2011
Streptococcus pneumoniae, also known as the pneumococcus, is an important cause of morbidity and mortality in the developed and developing world. Pneumococcal conjugate vaccines were first introduced for routine use in the USA in 2000, although the seven-
Gladstone, R.A.   +11 more
core   +1 more source

Pneumococcal Vaccination among Adults with Respiratory Diseases-Indications, Adherence and Roadblocks [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2018
Introduction: Globally, invasive pneumococcal disease poses a major challenge to the health system and causes significant economic burden. Pneumococcal vaccination is a recommended and well adhered practice among paediatric age groups as opposed to adult
Divya Ramachandran   +3 more
doaj   +1 more source

Impact of COVID-19 Outbreak on Influenza and Pneumococcal Vaccination Uptake: A Multi-Center Retrospective Study

open access: yesVaccines, 2023
During the coronavirus disease 2019 (COVID-19) pandemic, global vaccination efforts declined due to the burden on health systems and community resistance to epidemic control measures.
Chieh Lan   +3 more
doaj   +1 more source

Pneumococcal vaccine for asthma

open access: yesCochrane Database of Systematic Reviews, 2002
Infection with Streptococcus pneumoniae is an important cause of pneumonia and other serious illnesses, particularly amongst those with certain high-risk medical conditions such as asthma. Although pneumococcal vaccine is routinely advocated for people with asthma, there is uncertainty about the evidence base that underpins this recommendation.To ...
A, Sheikh, B, Alves, S, Dhami
openaire   +4 more sources

Streptococcus pneumoniae Septic Arthritis in a Vaccinated Host: Case Report

open access: yesTranslation
Streptococcus pneumoniae septic arthritis is an uncommon infection, rarely encountered in the US since the introduction of pneumococcal vaccination.  We present a case of S.
Joan Duggan   +4 more
doaj   +1 more source

The role of Pneumococcal vaccine [PDF]

open access: yesPulmonary Pharmacology & Therapeutics, 2008
Streptococcus pneumoniae pathologies represent a health problem of primary importance worldwide in terms of morbidity, mortality, and costs. S. pneumoniae is the main aetiological agent of bacterial pneumonia, and is frequently involved in bacterial meningitis, chronic obstructive pulmonary disease (COPD) exacerbations and upper airway pathologies. The
BRAIDO, FULVIO   +4 more
openaire   +5 more sources

Expert Consensus on the Diagnosis and Monitoring of Paroxysmal Nocturnal Hemoglobinuria (PNH): An Algorithmic Approach in an Era of New Treatments

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematologic disorder caused by a defect of glycosylphosphatidyl‐anchored proteins, leading to an uncontrolled complement‐mediated hemolysis. The advent of complement inhibitors in clinical practice radically changed patients' outcomes and survival.
Bruno Fattizzo   +8 more
wiley   +1 more source

Analysis of the Compliance of the Vaccination Schedule against Pneumococcal Infection in Young Children

open access: yesЭпидемиология и вакцинопрофилактика, 2018
Background. Vaccination is considered by the world community as the main measure of the fight against pneumococcal infection [1–3]. Immunization of children has been carried out since the end of 2014.  Goals.
I. V. Feldblium   +4 more
doaj   +1 more source

Inflammation Unchecked: Concurrent Kawasaki Disease and Stevens‐Johnson Syndrome in an 18‐Month‐Old Child

open access: yes
Arthritis Care &Research, EarlyView.
Catherine Deffendall   +6 more
wiley   +1 more source

Preventing infections after CD19‐directed chimeric antigen receptor T‐cell therapies for lymphoma: a consensus practice statement

open access: yesInternal Medicine Journal, EarlyView.
Abstract Chimeric antigen receptor (CAR) T‐cell therapies directed against cluster of differentiation 19 (CD19) are a standard of care for relapsed or refractory B‐cell lymphomas. Infection is the leading cause of non‐relapse mortality, and this risk may persist for years after CAR T‐cell receipt.
Aine Hurley   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy